However in blood from all of the ALS patients, the levels of RanGTPase after the 1 h incubation of whole blood extracts were greatly diminished, consistent with what would be expected for degradation of all RanGTPase as an extreme feedback response to the progression of ALS. The gene discussed is RAN; the disease is amyotrophic lateral sclerosis.